Newly discovered mechanism of T-cell control can interfere with cancer immunotherapies. ScienceDaily. Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2024 / 05 / 240503172616.htm.

T helper (TH) cells are essential immune cells that help other immune cells function effectively. When activated in response to environmental stimuli, these cells can differentiate into either TH1 ...

Autoimmune diseases, such as multiple sclerosis (MS), inflammatory bowel disease (IBD), and rheumatoid arthritis (RA), affect ...

U.S. and Chinese researchers appear to have unlocked a novel way to stop T cells from attacking the body in MS and other ...

More information: David Stahl et al, CSF1R + myeloid-monocytic cells drive CAR-T cell resistance in aggressive B cell lymphoma, Cancer Cell (2025). DOI: 10.1016/j.ccell.2025.05.013 Provided by ...

A new 3D imaging technique brings the working mode of T-cell immunotherapies into live view. T-cell immunotherapy is already leading to promising results in some children with leukemia.

Cytotoxic T cells, also known as the “killer” T cells, provide the foundation for cell-based CAR T therapy. The therapy borrows and enhances the T cell’s ability to kill multiple targets in ...

The effect of M-T807R1 administration and RAL monotherapy on blood CD8 + T cell dynamics. The effects of M-T807R1 on the dynamics of CD8 cells in individual macaques of a CD8 depletion group (n ...

Immune cells are known to sometimes share proteins in this way in a process called trogocytosis, Barbera said, but nobody had tried to see if CAR-T cells can donate their CARs to other T cells.

Newly discovered mechanism of T-cell control can interfere with cancer immunotherapies Peer-Reviewed Publication. German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) ...

Citation: Newly discovered mechanism of T-cell control can interfere with cancer immunotherapies (2024, May 3) ...